Marcin Renke

Summary

Country: Poland

Publications

  1. ncbi request reprint Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis
    Marcin Renke
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Scand J Urol Nephrol 38:427-33. 2004
  2. doi request reprint The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study
    Marcin Renke
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Kidney Blood Press Res 31:404-10. 2008
  3. doi request reprint Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study
    Leszek Tylicki
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Scand J Urol Nephrol 42:381-8. 2008
  4. doi request reprint Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease
    Sławomir Lizakowski
    Department of Nephrology, Transplantation and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Am J Hypertens 25:636-9. 2012
  5. ncbi request reprint The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study
    Marcin Renke
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Med Sci Monit 16:PI13-8. 2010
  6. doi request reprint Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial
    Leszek Tylicki
    Department of Nephrology Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Am J Kidney Dis 52:486-93. 2008
  7. ncbi request reprint Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis
    Leszek Tylicki
    Department of Nephrology, Medical University of Gdansk, 80 211 Gdansk, Poland
    Med Sci Monit 11:PI31-7. 2005
  8. ncbi request reprint Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients
    Marcin Renke
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Scand J Urol Nephrol 39:511-7. 2005
  9. pmc Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial
    Sławomir Lizakowski
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Int Urol Nephrol 44:1763-70. 2012
  10. ncbi request reprint Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation
    Leszek Tylicki
    Department of Nephrology, Medical University of Gdansk, Poland
    Am J Nephrol 22:356-62. 2002

Collaborators

Detail Information

Publications25

  1. ncbi request reprint Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis
    Marcin Renke
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Scand J Urol Nephrol 38:427-33. 2004
    ..Clinical data comparing the renal effects of ACEIs and ARBs, either singly or in combination, are scarce and usually concern the use of standard or high doses...
  2. doi request reprint The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study
    Marcin Renke
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Kidney Blood Press Res 31:404-10. 2008
    ..There is still no optimal therapy which can stop the progression of chronic kidney disease. Antioxidants such as N-acetylcysteine (NAC) have been reported as a promising strategy in this field...
  3. doi request reprint Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study
    Leszek Tylicki
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Scand J Urol Nephrol 42:381-8. 2008
    ..To improve renal outcome one may consider using increased dosages of ACEI above those usually recommended for hypertension...
  4. doi request reprint Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease
    Sławomir Lizakowski
    Department of Nephrology, Transplantation and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Am J Hypertens 25:636-9. 2012
    ....
  5. ncbi request reprint The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study
    Marcin Renke
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Med Sci Monit 16:PI13-8. 2010
    ..Antioxidants, e.g., N-acetylcysteine (NAC), have been suggested as a promising medicament in this field...
  6. doi request reprint Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial
    Leszek Tylicki
    Department of Nephrology Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Am J Kidney Dis 52:486-93. 2008
    ....
  7. ncbi request reprint Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis
    Leszek Tylicki
    Department of Nephrology, Medical University of Gdansk, 80 211 Gdansk, Poland
    Med Sci Monit 11:PI31-7. 2005
    ..The aim of this study was to evaluate the effects of low-dose (25 mg) losartan on proteinuria and tubular injury extent...
  8. ncbi request reprint Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients
    Marcin Renke
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Scand J Urol Nephrol 39:511-7. 2005
    ..This therapeutic strategy is not used for proteinuric patients who are not able to receive high doses of angiotensin-converting enzyme inhibitor or angiotensin II receptor antagonists...
  9. pmc Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial
    Sławomir Lizakowski
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Int Urol Nephrol 44:1763-70. 2012
    ..To evaluate the proteinuria-lowering effect of a renin inhibitor (aliskiren), compared to placebo and to an angiotensin-converting enzyme inhibitor (perindopril), in patients with non-diabetic chronic kidney disease...
  10. ncbi request reprint Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation
    Leszek Tylicki
    Department of Nephrology, Medical University of Gdansk, Poland
    Am J Nephrol 22:356-62. 2002
    ..However, there is lack of data concerning renoprotective action of very small doses of these drugs...
  11. ncbi request reprint Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis
    Przemyslaw Rutkowski
    Department of Nephrology, Transplantology, and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Am J Kidney Dis 43:260-8. 2004
    ..We compared the concomitant use of benazepril, 5 mg, and losartan, 25 mg, and monotherapy with these agents in doses 2-fold greater...
  12. ncbi request reprint Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study
    Marcin Renke
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
    Acta Biochim Pol 57:119-23. 2010
    ..Pentoxifylline (PTE) is a non-specific phosphodiesterase inhibitor with anti-inflammatory properties. It has been reported to have promising effects in CKD treatment...
  13. ncbi request reprint Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease
    SÅ‚awomir Lizakowski
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland
    Pol Arch Med Wewn 123:221-7. 2013
    ..Therapies involving direct renin inhibitor, aliskiren, may promote renal fibrosis by stimulating (pro)renin receptor due to increased renin levels...
  14. ncbi request reprint Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study
    Marcin Renke
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Poland
    Acta Biochim Pol 57:547-52. 2010
    ..A number of experimental models demonstrate a beneficial effect of statins in ameliorating renal damage. However, the exact mechanism by which statins protect against renal damage remains unclear...
  15. ncbi request reprint Relationship between uremic toxins and oxidative stress in patients with chronic renal failure
    Przemyslaw Rutkowski
    Department of Nephrology, Transplantology and Internal Diseases, Medical University of Gdansk, Gdansk, Poland
    Scand J Urol Nephrol 41:243-8. 2007
    ..The aim of this study was to elucidate potential relationships between N-methyl-2-pyridone-5-carboxamide (Me2PY) and N-methyl-4-pyridone-5-carboxamide (Me4PY), two uremic compounds, and different parameters of oxidative stress...
  16. doi request reprint Estimation of oxidative stress markers in chronic kidney disease
    Agnieszka Kuchta
    Department of Clinical Chemistry, Medical University of Gdansk, Gdansk, Poland
    Kidney Blood Press Res 34:12-9. 2011
    ..We also showed that estimating total antioxidant status in a simple test is unreliable for assessing the antioxidant ability of patients with CKD...
  17. doi request reprint The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?
    Leszek Tylicki
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Poland
    Kidney Blood Press Res 36:335-43. 2012
    ..The aim was to compare the effects on albuminuria of the therapy with either: (i) telmisartan 80 mg and aliskiren 300 mg, (ii) telmisartan 80 mg and eplerenone 50 mg, (iii) telmisartan 160 mg as monotherapy...
  18. ncbi request reprint Short-term effects of angiotensin II receptor blockade in patients with primary glomerulonephritis: pilot study
    Leszek Tylicki
    Department of Nephrology, Transplantology and Internal Medicine, Medical University, Gdansk, Poland
    J Ren Nutr 12:122-5. 2002
    ..The aim of the present study was to investigate renal and metabolic effects of specific AT-1 receptor blocker-losartan in patients with primary glomerulonephritis...
  19. ncbi request reprint Interrelationship between uremic toxicity and oxidative stress
    Przemysław Rutkowski
    Department of Nephrology, Transplantology, and Internal Diseases, Medical University of Gdansk, Gdansk, Poland
    J Ren Nutr 16:190-3. 2006
    ..Nevertheless, further complex studies are needed to elucidate closer pathogenic links...
  20. ncbi request reprint [Pentoxifylline old drug or new hope for nephrology?]
    Marcin Renke
    Katedra i Klinika Nefrologii Transplantologii i Chorób Wewnetrznych Akademia Medyczna, Gdansk
    Przegl Lek 65:358-61. 2008
    ..This may occur due to inhibition of proinflammatory cytokine production. Probably in the next few years we will get answer to the question of PTF role in nephrology...
  21. ncbi request reprint [Groin hernia in the patients receiving CAPD]
    Maciej Smietanski
    Z Katedry i Kliniki Chirurgii Ogólnej i Transplantacyjnej, Akademii Medycznej w Gdansku
    Wiad Lek 58:553-6. 2005
    ....
  22. ncbi request reprint [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline]
    Marcin Renke
    Katedra i Klinika Nefrologii, Transplantologii i Chorób Wewnetrznych AM, Gdansk 80 211, ul Debinki 7
    Przegl Lek 65:312-4. 2008
    ..8 g, serum creatinine was 1.4 mg/dl and potassium 5.4 mmol/l. Next PTF 800 mg/day was added and DPE fell to 0.55 g after 2 months' therapy. Similar DPE was after 6 months (0.53 g) since we started with combination of IKA, ARA and PTF...
  23. doi request reprint Therapy outcome in peritoneal dialysis patients transferred from haemodialysis
    Tomasz Liberek
    Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Poland
    Nephrol Dial Transplant 24:2889-94. 2009
    ..The effects of these transfers on therapy outcome, patient and technique survival have not been studied, with research focusing on outcome measures within the single modality and comparisons between the two methods...
  24. doi request reprint Spironolactone attenuates oxidative stress in patients with chronic kidney disease
    Marcin Renke
    Hypertension 52:e132-3; author reply e134. 2008
  25. doi request reprint Effects of N-acetylcysteine on angiotensin-converting enzyme plasma activity in patients with chronic kidney diseases
    Leszek Tylicki
    Blood Purif 26:354. 2008